-
Thematic Analysis
NewEnterprise Security Software Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Artificial intelligence (AI) is a double-edged sword in cybersecurity. It can help organizations improve their threat detection, hunting, and incident response capabilities, but adversaries can and will use AI in cyberattacks. There is every likelihood that AI will spur new merger and acquisition (M&A) deals in cybersecurity, especially of companies judged to be AI specialists. In the thematic screen of GlobalData’s enterprise security software sector scorecard, AI has a weighting of 20%, higher than any other theme.
-
Product Insights
NewLikelihood of Approval Analysis for Binge Eating Disorder
Overview How likely is it that the drugs in Binge Eating Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Binge Eating Disorder Overview Binge eating disorder is a serious condition...
-
Sector Analysis
NewAutomotive Vehicle Lightweighting Market Trends, Sector Overview and Forecast to 2028
Reasons to buy the ‘Automotive Vehicle Lightweighting’ market report: Trends & Drivers: Provides an overview of the current sector scenario regarding the future outlook in terms of key trends and drivers of the sector. Technological Developments: Provides a detailed overview of technological developments and innovations in the sector. PESTER Analysis: Provides a detailed understanding of various factors such as political, economic, social, technological, environmental, and regulatory impacting the sector. Competitive Landscape: Provides an overview of leading component suppliers at a...
-
Product Insights
NewLikelihood of Approval Analysis for Appetite (Eating) Disorders
Overview How likely is it that the drugs in Appetite (Eating) Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Appetite (Eating) Disorders Overview Appetite (eating) disorders are psychological conditions that...
-
Product Insights
NewLikelihood of Approval Analysis for Osteoarthritis Pain
Overview How likely is it that the drugs in Osteoarthritis Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Osteoarthritis Pain Overview Osteoarthritis pain, the hallmark symptom of this degenerative joint...
-
Thematic Analysis
NewSemiconductors Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Companies scoring strongly in artificial intelligence (AI) and geopolitics-related themes lead the thematic screen of GlobalData’s semiconductors sector scorecard. Indeed, the AI, AI chips, geopolitics, and China impact themes jointly account for 50% of the weighting of the thematic screen, reflecting both the growing importance of AI, particularly generative AI, in the industry and the impact of the ongoing US-China trade dispute. Among the thematic leaders are companies with either advanced AI products, such as Nvidia, Amazon, Tesla, and Alibaba,...
-
Product Insights
NewLikelihood of Approval Analysis for Pituitary Gland Disorders
Overview How likely is it that the drugs in Pituitary Gland Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pituitary Gland Disorders Overview Pituitary gland disorders involve dysregulation of the...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Bile Duct Cancer
Overview How likely is it that the drugs in Metastatic Bile Duct Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Bile Duct Cancer Overview Cholangiocarcinoma, also known as bile...
-
Product Insights
NewLikelihood of Approval Analysis for Gastric Ulcers
Overview How likely is it that the drugs in Gastric Ulcers will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gastric Ulcers Overview Gastric ulcer is a painful sore or ulcer in...
-
Product Insights
NewLikelihood of Approval Analysis for Graft Versus Host Disease (GVHD)
Overview How likely is it that the drugs in Graft Versus Host Disease (GVHD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Graft Versus Host Disease (GVHD) Overview Graft-versus-host disease (GVHD)...